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ABSTRACT 
In this study, the interaction of an anticancer drug, Capecitabine with DNA was investigated by 
electrochemical methods using carbon paste electrode (CPE). The interaction of Capecitabine with 
single-stranded Calf thymus DNA (ss DNA) and double-stranded Calf thymus DNA (ds DNA) at 
electrode surface, or in solution phase was investigated by monitoring the changes at the oxidation 
signal of guanin base of DNA measured by differential pulse voltammetry (DPV) technique. 
Impedimetric measurements were performed by electrochemical impedance spectroscopy technique that 
also confirmed that ds DNA was immobilized onto the electrode surface. The detection limit (DL) in the 
case of interaction of Capecitabine with dsDNA and ssDNA interaction was calculated and found to be 
17.35µg/mL and 17.12µg/mL, respectively. 
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INTRODUCTION 
Biosensors are obtained by incorporating biological substances such as enzymes, cells, 
tissues, antibodies, nucleic acids into the structure of an electrochemical sensor (Özsöz., et al 
2002; Wang, 2002). DNA biosensors are biosensors in which DNA is used as the biological 
material that recognizes it by interacting with the substance to be analyzed (Wang, 1997; 
Erdem, 2007) . DNA biosensors are used to elucidate the effects of certain DNA - targeted 
drugs or substances on DNA and to determine the interaction mechanisms of these substances 
(Wang, 1997; Nawaz, et al., 2006). Drug interaction with nucleic acids is one of the most 
important factors in the design of drugs and the development of related processes (Erdem, 
2002). Many different techniques are used to examine drug - DNA interaction, which have 
several advantages and disadvantages. Therefore, the demand for new techniques for drug 
design and process development based on drug-DNA interaction is increasing (Özsöz, et al., 
2002; Nawaz, et al., 2006). 
Electrochemical DNA biosensors consist of a nucleic acid recognition layer 
immobilized to the electrochemical transducer (Rauf, et al., 2005; Erdem and Özsöz, 2001). 
The nucleic acid recognition layer detects changes in DNA structure or the specific sequence 
of DNA during the interaction of the binding molecules with DNA. DNA - drug interaction 
mechanism can be explained using the difference between pre - and post - interaction measured 
signals (Erdem and Özsöz., 2001). This interaction is also used to determine the quantity of the 
drugs analyzed or to design new drugs (Rauf, et al., 2005). During the design of many newly 
synthesized substances, drugs and especially DNA - targeted carcinogenic drugs, rapid and 
effective clarification of the interaction of these substances with DNA will enable these studies 
to progress more rapidly for their purposes. DNA - drug interactions can be detected 
successfully using DNA biosensors. This detection can be achieved by the guanine/adenine 
signal, which is the electroactive bases of the DNA, or by the electrochemical signal of the drug 
to be analyzed. DNA - drug interactions can be interpreted according to the changes in these 
signals (Wang, et al., 1998). Biosensors containing the nucleic acid (DNA) recognition surface 
are used for purposes such as elucidating or quantifying the interaction mechanism of the 
substance to be analyzed (carcinogenic substances, drugs, etc.) that interact with this surface, 
or monitoring hybridization events in certain regions of the base sequence in DNA (Wang, et 
al., 1998). Interaction of DNA with certain drug molecules (especially interaction with drug 
molecules with anticancer properties) and determination of this interaction with new methods 
developed is highly important for new product designs. The rapid detection of by - products 
that may occur in DNA after the interaction of a chemical substance or metabolite with DNA 
is very important for cancer research (Mikkelsen, 1996). There are many publications in the 
literature on DNA – drug interaction. In one of them, in the study of anticancer herbal medicine 
emodin with differential pulse voltammetry technique and using alternating voltammetry 
technique (L. Wang et al., 2006). found that emodine intercalated into DNA double helix 
structure and interacted with DNA. In another study; according to the study of ( H. Nawaz et 
al, 2006) with ciprofloxacin having antibacterial effect of quinoline derivative, it showed that 
ciprofloxacin binds to DNA electrostatically and by intercalation (Niu, et al., 2008).  
Many antitumor drugs show their effect by binding to DNA (Wang, et al., 2006, 
Richardson and Springfield., 1981). This information provides an opportunity to examine 
whether many compounds have potential to be used as anticancer drugs. In similar studies based 
on drug - DNA interaction, electrochemical studies (Marin, et al., 1998) have shown that drugs 
that interact with DNA cause a decrease or increase in the electrochemical response (Wang, et 
al., 1996; Yan, et al., 2001 ). Changes in the signals of electroactive bases in DNA or changes 
in the electrochemical signal of the substance to be analyzed provide reliable interactions 
between the analyte and DNA. In this study, the interaction and electrochemical behavior of 
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the anticancer drug, capecitabine, with single - use CPE modified or unmodified by DNA were 
investigated. DNA – drug interactions can be classified in two ways as interaction in solution 
phase and interaction on the electrode surface (İnteraction on the DNA modified electrode 
surface, interaction on the surface of the drug modified electrode). In this study, the interactions 
in solution phase and DNA modified electrode surface will be examined. The amount of 
capecitabine will be calculated based on reductions in the signal of the electroactive guanine 
base of DNA. In addition, when the capecitabine concentration is changed, parameters such as 
the response of the guanine signal, duration of interactions, and reproducibility will be 
examined. Although there have been many studies on anticancer drugs in the literature, no 
studies have examined the capecitabine - DNA interaction with CPE. In this respect, our study 
will eliminate an important deficiency in the literature (Palecek, 1996). 
MATERIALS and METHODS 
Devices Used  
Scales (Precisa XB 220A), Sound vibrating cleaner (Bandelin Sonorex), pH - meter 
(WTW series), Magnetic stirrer (AGE velp), Vortex (Velp scientifics), Potentiostat 
(AUTOLAB 302, GPRES 4.9 software, Eco Chemie), Ag/AgCl reference electrode, Platinum 
wire ( used as auxiliary electrode ). 
Chemicals Used  
Capecitabine (CPT) (Sigma), Acetic acid (99-100%) (Sigma-Aldrich), Hydrochloric 
acid (37%) (Sigma-Aldrich), Sodium Hydroxide (Sigma), Tris (hydroxymethyl) aminomethane 
hydrochloride (Sigma), Sodium chloride (Sigma), EDTA disodium salt (Sigma), Calf thymus 
ds-DNA (Sigma), Calf thymus ss-DNA (Sigma), 18 mega-ohm ultra-pure water was used in all 
studies. Experimental studies were performed at room temperature (25.0 ± 0.5 ° C). 
Preparation of the solutions used  
Preparation of buffer solutions:  
Preparation of 0.05 M phosphate buffer solution ( pH 7.4; PBS ): The 0.05 M phosphate 
buffer solution used during the measurements contained 1.36g ( 0.01 mol ) KH2PO4, 6.96 g ( 
0.04 mol ) KH2PO4 and 1.168 g NaCl ( 0.02 mol ) per liter. 
Preparation of 0.50 M acetate buffer solution  (pH 4.81; ABS ): The 0.5 M acetate buffer 
solution contains about 29 mL of concentrated acetic acid per L and 1.168 g NaCl. The pH of 
the buffer solution was adjusted to 4.81 with 0.1 M NaOH solution.  
Preparation of 0.01 M Tris-HCl, 1 mM EDTA buffer solution ( pH 8.0;Tris-EDTA): The 
0.01 M Tris-HCl, 1 mM EDTA buffer solution used contains 1.576 g Tris HCl and 0.372 g 
EDTA per liter. The pH of the solution was adjusted to 8.0 by adding 0.1 N NaOH and/or 0.1 
N HCl measured with the pH meter. 
 Preparation of the Capecitabine solution: The stock solutions of the purchased 100% 
pure Capecitabine with ABS buffer were prepared and stored at 4◦C by placing them in 
eppendorf tubes in volumes of 50μL for later use.  
Preparation of DNA solutions: DNA from Calf thymus gland ( = Calf thymus DNA ); 
double-stranded DNA ( ds DNA ) stock solutions; 1000μg/mL was prepared with TE solution 
( 10 mM Tris-HCl, 1 mM EDTA, pH 8.0 ) and stored below zero [ 21 ]. The Ct - ds DNA dilute 
solution was prepared with 0.5M Acetate buffer ( pH 4.8 ). To minimize the exposure of the 
solution to light, it was stored in the refrigerator at -20◦C in a non-light box. The single stranded 
DNA (ss DNA) solution was also prepared as described above for ct - ds DNA and was stored 
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in the refrigerator at -20◦C. The single-stranded DNA (ss DNA) solution was also prepared as 
described above for ct - ds DNA and stored in the refrigerator at -20 °C. 
General information about Capecitabine (CPT) 
Figure 1: Structural formula of Capecitabine (C15H22FN3O6). 
 
 
Pharmacological Properties: Capecitabine is a cancer ( chemotherapeutic ) drug. It 
prevents the prolifereation of cancer cells. Slows down their development. And slows down 
their spread in the body. Capecitabine is a non-cytotoxic fluoropyrimidine carbamate that acts 
as an orally administered prodrug of the cytotoxic 5-fluorouracil (5-FU). Capecitabine is 
activated through several enzymatic steps. In the last step, thymidine phosphorylase (ThyPase), 
an enzyme involved in its conversion to 5-FU, is found in tumor tissues; this enzyme is also 
found in normal tissues but is usually at lower levels. In human cancer xenograft models, 
capecitabine showed a synergistic effect in combination with docetaxel; this effect may be due 
to the increase in thymidine phosphorylase functions by docetaxel. There is evidence that the 
metabolism of 5- FU in the anabolic pathway blocks the methylation reaction of deoxyuridylic 
acid to thymidilic acid, thereby inhibiting deoxyribonucleic acid (DNA) synthesis. 5-FU 
formation also results in inhibition of RNA and protein synthesis. Since DNA and RNA are 
essential for cell division and growth, the effect of 5-FU may be to produce a thymidine 
insufficiency that causes cell unstable growth and death. The effects of blocking DNA and RNA 
synthesis are evident on cells that proliferate and metabolize 5-FU faster. Studies have 
supported the use of Xeloda as a first-line treatment for metastatic colorectal cancer. Data from 
a multicentered, randomized, controlled phase III trial support the use of Xeloda in combination 
with docetaxel after the failure of anthracycline-containing cytotoxic chemotherapy to treat 
patients with locally advanced or metastatic breast cancer. In addition, data from multicentered 
two-phase II studies support the use of Xeloda monotherapy for the treatment of patients after 
failure of the taxanes and anthracycline-containing chemotherapy regimen, or for whom further 
anthracycline treatment is not indicated (Karadeniz, et al., 2007).   
Method Used  
For the steps regarding the activation of the electrodes used and attachment of ct - ds 
DNA and ct - ss DNA to the electrode surface, interaction of DNA material with the material 
examined on the electrode surface, the path reported in the current literature (Erdem, et al., 
1999; Kuralay, et al., 2009; Wang, et al., 2001) was followed. The electrode was renewed each 
time and repeated 5 times in succession and current values were measured.  
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Preparation of electrodes used 
In this study, using the differential pulse voltammetry technique, μ-AUTOLAB III (Eco 
Chemie, Netherlands) was used as the potentiostat device and GPES 4,9 was used as the 
software program. As the triple electrode system, carbon paste electrode was used as working 
electrode, Ag/AgCl was used as reference electrode and platinum wire was used as counter 
electrode. Each electrode was connected to the system by metal connections and this triple 
electrode was adjusted to a volume of 6 mL of the measuring solution into which the system 
was immersed.  
Carbon Paste Electrode (CPE) Preparation: The working electrode is made of 3 mm 
diameter glass tube and contains carbon paste inside, and electrical conductivity is provided by 
copper wire. The carbon paste was prepared by homogeneous mixing of graphite powder and 
mineral oil at a ratio of 70: 30. After the electrode (CPE) was prepared, the electrode surface 
was turned into a homogeneous surface with parchment paper (Wang, 1997; Erdem and Özsöz, 
2001; Wang, et al., 1996).  
Electrochemical Impedance Spectroscopy (EIS) Measurements: After the DNA (ct - ds 
DNA and ct – ss DNA) immobilization optimization and DNA - CPT interaction optimization 
for the working electrode, necessary solutions were prepared and measurements were taken for 
EIS experiments. Solutions were prepared containing 164.5mg K3Fe(CN)6 (molecular mass: 
329.243 g) and 208.13 mg K4Fe(CN)6.3H2O (molecular mass: 422,38 g) redox probes in which 
measurement would be made with different pH values. To the prepared redox solution probe 
[Fe (CN)63-/4-1.49 g of KCl was added (for 200 mL) to keep the ionic strength constant. The 
redox pair probe was adjusted in this way in all experiments. In electrochemical impedance 
spectroscopy experiments, Ag/AgCl was used as reference electrode and Pt wire as auxiliary 
electrode. Using the Frequency Analyzer (FRA) software, the impedance of the solutions was 
obtained by electrochemical impedance spectroscopy technique. The impedance measurements 
were fixed at a wave height of 10 mV in the prepared redox solution so that the system 
properties were kept in equilibrium. In order to obtain Nyquist curves, the applied frequency 
was adjusted between 0.1 Hz and 100 kHz. As with all previous studies, the surface of the 
electrodes was refreshed each time, repeated 5 times in succession, and the surface resistance 
of the electrode was measured. 
RESULTS AND DISCUSSION 
DNA Immobilization on Activated CPE elektrod 
Passive adsorption was selected for CPE as the immobilization technique. Separate 
experiments were performed for ct - ds DNA and ct - ss DNA with activated carbon paste 
electrodes. Firstly, the optimal time of immobilization (Figure 2) and then the optimal DNA 
concentration for that time were optimized (Figure 3) by keeping the concentrations of DNA 
to be immobilized constant. Guanine peak current values obtained from DPV measurements 
were used to optimize both time and DNA concentration. To do this, the triple electrode system 
was immersed into the electrochemical cell and then voltammetric measurement was 
performed. The oxidation signals of guanine were measured in ABS (pH 4.8) by DPV 
(Differential Pulse Voltammetry) technique with a scanning speed of 50 mV/s and pulse 
amplitude of 50 mV between 0.2 V and 1.4 V.  
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Figure 2: Voltamograms (A) and histograms (B) showing guanine signals measured by DPV 
technique after interaction of ct - ds DNAs immobilized on CPE surface at different times: (a) 
1 (b) 3 (c) 5  (d) 7 (e) 9 (f) 11 min 
 
 
Figure 3: In the absence of (a) ct - ds DNA immobilized on the CPE surface, voltamograms 
(A) and histograms (B) showing guanine signals measured by DPV technique of ct - ds DNA 
at different concentrations: (b) 12, (c) 18, (d) 24, (e) 30, (f) 36, (g) 42 µg/mL 
 
 
Time and concentration optimization in DNA immobilization was performed separately 
for both ct - ds DNA and ct - ss DNA. As shown in Figure 2 and Figure 3, while the optimum 
interaction time for ct - ds DNA was found to be 9 minutes most favorable for reproducibility 
and 42μg/mL for ct - ds DNA concentration, this time was determined as 9 minutes for ct - ss 
DNA and 36 μg/mL for ct ss-DNA (not shown). 
Optimization studies of CPT (Capecitabine) interaction with immobilized DNA 
(ct-dsDNA and ct- ssDNA) on CPE surface 
Ct - ds DNA and ct - ss DNA immobilized CPEs were incubated at 110 ’µL of solutions 
containing Capecitabine at various concentrations for various periods of time, and the optimal 
time for DNA-drug interaction (Figure 4) and then the optimal drug concentration for this time 
(Figure 5) was determined. Reductions in guanine peak currents after DNA - drug interaction 
were utilized in the optimization processes. The oxidation signals of guanine were measured in 
ABS  (pH 4.8) by DPV technique with a scanning speed of 50 mV/s and pulse amplitude of 50 
mV between 0.2 V and 1.4 V. 
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Figure 4: Response effect of CPT immobilization time: Voltamogram (A) and histogram (B) 
showing guanine signals measured by DPV technique by immersing at different times: (a) 
without CPT , with ct - ds DNA, (b) 1, (c) 2, (d) 3, (e) 4 ,(f) 5 min interacting whit ct - ds 
DNA immobilized CPEs in CPT solution 
 
 
Figure 5: Response effect of CPT concentration: Voltamogram (A) and histogram (B) 
showing guanine signals measured by DPV technique by immersing in CPT solutions of 
different concentrations such as ct - ds DNA immobilized CPE's (a) without ct - ds DNA (b) 
without CPT, with ct - ds DNA (c) 10 (d) 20 (e) 30 (f) 40 (g) 50 mg/ml. 
 
 
Time and concentration optimization in DNA - CPT interaction was performed 
separately for both ct - ds DNA and ct - ss DNA. As shown in Figure 4 and Figure 5, the 
optimal interaction time for ct - ds DNA with CPT was found to be optimal 3 minutes for 
reproducibility and the CPT concentration was 40 μg/mL, while this time was 3 minutes and 
the CPT concentration was 30 μg/mL  for for ct - ss DNA-CPT interaction (not shown). 
Calibration curves for both ct - ds DNA - CPT and ct - ss DNA - CPT interactions using the 
data obtained are shown in Figure 6 and Figure 7.  
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Figure 6: Calibration curve of CPT concentration change in CPT interaction with ct - ds 
DNA immobilized on CPE surface. 
 
 
Figure 7: Calibration curve of CPT concentration change in CPT interaction with ct - ss DNA 
immobilized on CPE surface. 
 
 
Determination limits were calculated according to the regression equation (y=0,044x + 
0.071) of the calibration plot plotted for ct - ds DNA - CPT interaction with DL = yB + 3 sB 
correlation (yB: blind signal; sB: blind standard deviation; n = 4) and the regression equation  
(y=0.0056x + 0.0448) of the calibration plot plotted for ct - ss DNA - CPT interaction. The 
minimum detection limit for ct - ds DNA - CPT interaction was 17.35 μg/mL and the lowest 
detection limit for ct – ss DNA - CPT interaction was 17.12 mg/mL. 
Results of Electrochemical Impedance (EIS) Tests 
In this method, CPEs were activated by 1.4 V 60 seconds activation process applied in 
other studies. The only different step is the step where measurements are taken for EIS 
experiments using Frequency Analyzer (FRA) software instead of differential pulse 
voltammetry. After ct - ds DNA immobilization to the CPE surface at optimum conditions (42 
μg / mL, 9 minutes), EIS experiments were performed in redox solution. Ct - ds DNA - CPE 
interaction on the surface of the CPE after immersion of ct - ds DNA immobilized on the surface 
of the CPE was again measured for its resistance to the transferred current in the redox solution 
and shown in Figure 8 with the Nyquist curve generated from values close to the mean values. 
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Figure 8: (A) Niquist curve (B) Resistance of ct - ds DNA - CPT interaction to the transferred 
current load on the surface of the CPE; (a) resistance of activated CPEs, (b) resistance of ct - 
ds DNA immobilized CPEs, (c) resistance of ct - ds DNA - CPT interaction immobilized on 
CPE surface 
 
 
After ct – ss DNA was immobilized to the CPE surface at optimum conditions (36 
μg/mL, 9 minutes), all experiments on ct – ds DNA were repeated for ct – ss DNA. The 
resistance of the Ct - ss DNA - CPT interaction to the transferred current was measured and is 
shown in Figure 9 with the Nyquist curve generated from values close to the mean values.  
Figure 9: (A) Niquist curve (B) The resistance of the ct - ss DNA - CPT interaction to the 
transferred current load on the surface of the CPE; (a) resistance of activated CPEs, (b) 
resistance of ct - ss DNA immobilized CPEs, (c) Ct - ss DNA - CPT interaction immobilized 
on CPE surface 
 
According to electrochemical impedance measurements in DNA immobilization or after 
DNA - CPT interactions, electrode surface differentiated and load transfer resistances 
increased. 
CONCLUSION 
In our study for sensor-based DNA analysis, activation of carbon paste electrodes 
(CPE), optimization for double stranded DNA (ct – ds DNA) and single stranded DNA (ct – ss 
DNA) analysis and its interaction with capecitabine (CPT), an anticancer drug, were 
investigated with electrochemical methods. In this study, where carbon paste electrodes were 
used as working electrodes, electrochemical behavior was investigated by differential pulse 
voltammetry (DPV) technique. Electrochemical determination of DNA immobilized on the 
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CPE surface was performed by measuring the oxidation signal of guanine, the electroactive 
base of DNA by DPV technique. Moreover, the effect of CPT concentration, change in DNA 
concentration and surface activation on the response was investigated and highly good results 
were obtained in terms of reproducibility and sensitivity. Before examining the interaction of 
anti-cancer drug CPT with DNA, electrochemical behavior of the drug in the studied potential 
range was examined and no electroactive species was observed in this range. After the 
interaction of CPT with DNA, it was observed that the oxidation signal of the guanine base, an 
electroactive group of DNA, decreased due to increased drug concentration in DNA - drug 
interaction. This reduction in guanine signals is a result of the interaction of CPT with double - 
stranded DNA, in alignment with the results of similar studies in the literature ( Nawaz, et al., 
2006 ), and may be explained by the fact that groups suitable for oxidation in the structure of 
this molecule are partly present for the redox reaction after interaction. 
For immobilization of ct – ds DNA and ct – ss DNA on CPT surface, the optimized 
interaction time was 9 minutes for ct – ds DNA and 9 minutes for ct – ss DNA, the optimized 
amount of interaction was found to be 42 μg/mL for ct – ds DNA and 36 μg/mL for ct – ss 
DNA. In the examination of CPT - DNA interaction with DNA immobilized CPTs, the 
optimized interaction time was 3 minutes for ct – ds DNA and ct – ss DNA, the optimized 
amount of interaction was found to be 40 μg/mL for ct – ds DNA and 30 μg/mL for ct – ss 
DNA. In the examination of pH effect on CPE surface interactions, the pH of ct – ds DNA and 
ct – ss DNA was 4.8 and the guanine signal of ABS buffer was the highest.  
For immobilization of ct – ds DNA to the activated CPE surface, after the optimum 
concentration of ct – ds DNA was determined as 42 μg/mL and the optimum interaction time 
was determined as 9 minutes and ct – ds DNA - CPT interaction at the activated CPE surface 
was determined to have an optimal CPT concentration of 40 μg/mL and an optimum interaction 
time of 3 minutes, EIS measurements were taken for activated CPE, ct ds-DNA immobilized 
CPE and CPE after ct ds-DNA - CPE interaction. After ct – ds DNA immobilization, an increase 
in the resistance of the CPE surface compared to the previous state was observed and a decrease 
in the resistance after ct–ds DNA - CPT interaction was observed. As is known, the resistance 
and conductivity are inversely proportional, that is to say, the higher the resistance, the lower 
the conductivity. When the histogram is examined with this in mind, we can say that the 
activated CPE conductivity is higher than the CPE after ct – dsDNA immobilized CPE and ct 
– dsDNA - CPT interaction. In the immobilization of ct–ssDNA to the activated CPE surface, 
the optimum concentration of ct – ss DNA was determined as 36 μg/mL and the optimum 
interaction time was determined as 9 minutes. And after ct – ss DNA - CPT interaction at the 
activated CPE surface was determined as 30 μg/mL of optimum CPT concentration and 3 
minutes of optimum interaction time, EIS measurements were taken for activated CPE, ct – ss 
DNA immobilized CPE and CPE after ct – ssDNA - CPT interaction. After ct – ssDNA 
immobilization, it was observed that there was an increase in the resistance of the CPE surface 
compared to the previous state and a decrease in the resistance after ct – ss DNA - CPT 
interaction. Activated CPE conductivity was found to be higher than the CPE after ct – ss DNA 
immobilized CPE and ct – ss DNA - CPT interaction.  
As a result, it is seen that electrochemical sensors developed using designed DNA 
biosensors can provide more sensitive, reliable and selective results in the determination of drug 
- DNA interactions. It is important to investigate whether Capecitabine, a commonly used 
anticancer drug, has an interaction with DNA and to develop an inexpensive and inexpensive 
electrochemical method for the determination of such drugs in biological samples. 
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